“The Global Non-invasive Prenatal Testing Market will Grow to USD 9,551.47 Million by 2026, at a CAGR of 13.62%
”
FEATURED COMPANIES
- Berry Genetics
- BGI Group
- Eurofins LifeCodexx AG
- Hoffmann-La Roche Ltd.
- IGENOMIX
- Illumina, Inc.
- MORE
The Global Non-invasive Prenatal Testing Market size was estimated at USD 4,438.91 Million in 2020 and expected to reach USD 5,028.60 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.62% to reach USD 9,551.47 Million by 2026.
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
This research report categorizes the Non-invasive Prenatal Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Non-invasive Prenatal Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Non-invasive Prenatal Testing Market, including Agilent Technologies, Inc., Berry Genetics, BGI Group, Eurofins LifeCodexx AG, Hoffmann-La Roche Ltd., IGENOMIX, Illumina, Inc., Laboratory Corporation of America Holdings, NATERA, INC., and PerkinElmer Inc..
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
1. What is the market size and forecast of the Global Non-invasive Prenatal Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Non-invasive Prenatal Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-invasive Prenatal Testing Market?
4. What is the competitive strategic window for opportunities in the Global Non-invasive Prenatal Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Non-invasive Prenatal Testing Market?
6. What is the market share of the leading vendors in the Global Non-invasive Prenatal Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Non-invasive Prenatal Testing Market?
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Non-invasive Prenatal Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the Non-invasive Prenatal Testing Market was studied across Consumables and Instruments. The Consumables is further studied across Assay Kits & Reagents and Disposables. The Instruments is further studied across Microarrays, Next-generation Sequencing Systems, Polymerase Chain Reaction Instruments, and Ultrasound Devices.
- Based on Method, the Non-invasive Prenatal Testing Market was studied across Biochemical Screening Tests, Cell-free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests, and Ultrasound Detection.
- Based on Application, the Non-invasive Prenatal Testing Market was studied across Microdeletion Syndrome and Trisomy.
- Based on End User, the Non-invasive Prenatal Testing Market was studied across Diagnostic Laboratories and Hospitals.
- Based on Region, the Non-invasive Prenatal Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Non-invasive Prenatal Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Non-invasive Prenatal Testing Market, including Agilent Technologies, Inc., Berry Genetics, BGI Group, Eurofins LifeCodexx AG, Hoffmann-La Roche Ltd., IGENOMIX, Illumina, Inc., Laboratory Corporation of America Holdings, NATERA, INC., and PerkinElmer Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Non-invasive Prenatal Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Non-invasive Prenatal Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-invasive Prenatal Testing Market?
4. What is the competitive strategic window for opportunities in the Global Non-invasive Prenatal Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Non-invasive Prenatal Testing Market?
6. What is the market share of the leading vendors in the Global Non-invasive Prenatal Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Non-invasive Prenatal Testing Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Berry Genetics
- BGI Group
- Eurofins LifeCodexx AG
- Hoffmann-La Roche Ltd.
- IGENOMIX
- Illumina, Inc.
- MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Method Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
5.1.1.2. Growing preference for non-invasive techniques over invasive methods
5.1.1.3. Improving reimbursement policies for average and low-risk pregnancies
5.1.2. Restraints
5.1.2.1. Dearth of skilled professionals
5.1.3. Opportunities
5.1.3.1. Increasing awareness of NIPT
5.1.3.2. Untapped emerging markets such as China, India, Brazil, and Mexico
5.1.4. Challenges
5.1.4.1. Reliability of test results, especially in obese women
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Non-invasive Prenatal Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits & Reagents
6.2.2. Disposables
6.3. Instruments
6.3.1. Microarrays
6.3.2. Next-generation Sequencing Systems
6.3.3. Polymerase Chain Reaction Instruments
6.3.4. Ultrasound Devices
7. Non-invasive Prenatal Testing Market, by Method
7.1. Introduction
7.2. Biochemical Screening Tests
7.3. Cell-free DNA in Maternal Plasma Tests
7.4. Fetal Cells in Maternal Blood Tests
7.5. Ultrasound Detection
8. Non-invasive Prenatal Testing Market, by Application
8.1. Introduction
8.2. Microdeletion Syndrome
8.3. Trisomy
9. Non-invasive Prenatal Testing Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals
10. Americas Non-invasive Prenatal Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Non-invasive Prenatal Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand
12. Europe, Middle East & Africa Non-invasive Prenatal Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.2. Berry Genetics
14.3. BGI Group
14.4. Eurofins LifeCodexx AG
14.5. Hoffmann-La Roche Ltd.
14.6. IGENOMIX
14.7. Illumina, Inc.
14.8. Laboratory Corporation of America Holdings
14.9. NATERA, INC.
14.10. PerkinElmer Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2026 (%)
FIGURE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2026
FIGURE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 41. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2026
FIGURE 43. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 48. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2026
FIGURE 50. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 54. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SCORES
TABLE 54. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: RANKING
TABLE 57. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: LICENSE & PRICING
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Method Outlook
3.5. Application Outlook
3.6. End User Outlook
3.7. Region Outlook
3.8. Competitor Outlook
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of chromosomal abnormalities with increasing maternal age
5.1.1.2. Growing preference for non-invasive techniques over invasive methods
5.1.1.3. Improving reimbursement policies for average and low-risk pregnancies
5.1.2. Restraints
5.1.2.1. Dearth of skilled professionals
5.1.3. Opportunities
5.1.3.1. Increasing awareness of NIPT
5.1.3.2. Untapped emerging markets such as China, India, Brazil, and Mexico
5.1.4. Challenges
5.1.4.1. Reliability of test results, especially in obese women
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Non-invasive Prenatal Testing Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Assay Kits & Reagents
6.2.2. Disposables
6.3. Instruments
6.3.1. Microarrays
6.3.2. Next-generation Sequencing Systems
6.3.3. Polymerase Chain Reaction Instruments
6.3.4. Ultrasound Devices
7. Non-invasive Prenatal Testing Market, by Method
7.1. Introduction
7.2. Biochemical Screening Tests
7.3. Cell-free DNA in Maternal Plasma Tests
7.4. Fetal Cells in Maternal Blood Tests
7.5. Ultrasound Detection
8. Non-invasive Prenatal Testing Market, by Application
8.1. Introduction
8.2. Microdeletion Syndrome
8.3. Trisomy
9. Non-invasive Prenatal Testing Market, by End User
9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals
10. Americas Non-invasive Prenatal Testing Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Non-invasive Prenatal Testing Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Thailand
12. Europe, Middle East & Africa Non-invasive Prenatal Testing Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Agilent Technologies, Inc.
14.2. Berry Genetics
14.3. BGI Group
14.4. Eurofins LifeCodexx AG
14.5. Hoffmann-La Roche Ltd.
14.6. IGENOMIX
14.7. Illumina, Inc.
14.8. Laboratory Corporation of America Holdings
14.9. NATERA, INC.
14.10. PerkinElmer Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 (USD MILLION)
FIGURE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY REGION, 2020 (USD MILLION)
FIGURE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MARKET DYNAMICS
FIGURE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2026
FIGURE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, 2018-2026 (USD MILLION)
FIGURE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, 2018-2026 (USD MILLION)
FIGURE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, 2018-2026 (USD MILLION)
FIGURE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, 2018-2026 (USD MILLION)
FIGURE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, 2018-2026 (USD MILLION)
FIGURE 24. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 25. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, 2018-2026 (USD MILLION)
FIGURE 26. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 27. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, 2018-2026 (USD MILLION)
FIGURE 28. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 29. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2026 (%)
FIGURE 30. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2026
FIGURE 32. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, 2018-2026 (USD MILLION)
FIGURE 33. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 34. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, 2018-2026 (USD MILLION)
FIGURE 35. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 36. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, 2018-2026 (USD MILLION)
FIGURE 37. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 38. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, 2018-2026 (USD MILLION)
FIGURE 39. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 40. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 41. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2026
FIGURE 43. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, 2018-2026 (USD MILLION)
FIGURE 44. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 45. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, 2018-2026 (USD MILLION)
FIGURE 46. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 47. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 48. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2026
FIGURE 50. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2026 (USD MILLION)
FIGURE 51. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 52. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
FIGURE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD MILLION)
FIGURE 54. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 55. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 56. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 57. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 58. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 59. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 60. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 61. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 62. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 63. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 64. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 65. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 66. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 67. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 68. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 69. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 70. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 71. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 72. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 73. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 74. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 75. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 76. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 77. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 78. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 79. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 80. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 81. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 82. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 83. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: FPNV POSITIONING MATRIX
FIGURE 84. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 85. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
TABLE 5. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 6. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ASSAY KITS & REAGENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 7. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2026 (USD MILLION)
TABLE 8. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 9. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2026 (USD MILLION)
TABLE 10. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING SYSTEMS, BY REGION, 2018-2026 (USD MILLION)
TABLE 11. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION INSTRUMENTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 12. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2026 (USD MILLION)
TABLE 13. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY METHOD, 2018-2026 (USD MILLION)
TABLE 14. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY BIOCHEMICAL SCREENING TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 15. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY CELL-FREE DNA IN MATERNAL PLASMA TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 16. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY FETAL CELLS IN MATERNAL BLOOD TESTS, BY REGION, 2018-2026 (USD MILLION)
TABLE 17. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY ULTRASOUND DETECTION, BY REGION, 2018-2026 (USD MILLION)
TABLE 18. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 19. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY MICRODELETION SYNDROME, BY REGION, 2018-2026 (USD MILLION)
TABLE 20. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY TRISOMY, BY REGION, 2018-2026 (USD MILLION)
TABLE 21. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY END USER, 2018-2026 (USD MILLION)
TABLE 22. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2026 (USD MILLION)
TABLE 23. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD MILLION)
TABLE 24. AMERICAS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 25. ARGENTINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 26. BRAZIL NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 27. CANADA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 28. MEXICO NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 29. UNITED STATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 30. ASIA-PACIFIC NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 31. AUSTRALIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 32. CHINA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 33. INDIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 34. INDONESIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 35. JAPAN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 36. MALAYSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 37. PHILIPPINES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 38. SINGAPORE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 39. SOUTH KOREA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 40. THAILAND NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 42. FRANCE NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 43. GERMANY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 44. ITALY NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 45. NETHERLANDS NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 46. QATAR NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 47. RUSSIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 48. SAUDI ARABIA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 49. SOUTH AFRICA NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 50. SPAIN NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 51. UNITED ARAB EMIRATES NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 52. UNITED KINGDOM NON-INVASIVE PRENATAL TESTING MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 53. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SCORES
TABLE 54. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: BUSINESS STRATEGY
TABLE 55. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: PRODUCT SATISFACTION
TABLE 56. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: RANKING
TABLE 57. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 58. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: MERGER & ACQUISITION
TABLE 59. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 60. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 61. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: INVESTMENT & FUNDING
TABLE 62. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 63. GLOBAL NON-INVASIVE PRENATAL TESTING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
- Agilent Technologies, Inc.
- Berry Genetics
- BGI Group
- Eurofins LifeCodexx AG
- Hoffmann-La Roche Ltd.
- IGENOMIX
- Illumina, Inc.
- Laboratory Corporation of America Holdings
- NATERA, INC.
- PerkinElmer Inc.
Note: Product cover images may vary from those shown
LOADING...
